Advent of neurorehabilitation devices has unarguably expanded the armamentarium of neurologists, given the fact that the patients are unlikely to recover fully. The various neurorehabilitative treatments and therapies have undergone considerable shifts underpinned by technological advances. These have been frequented by robotic-based therapies, non-invasive brain stimulation devices, and neural interfaces. Of these, robotics has occupied a profound role in neurorehabilitation devices.
Industry players have been actively looking for new ways to leverage the potential of robotic devices in strokes, spinal cord injuries, and traumatic brain injuries. Criteria of product development in this regard have notably been influenced by proposition of satisfactory functional recovery. A growing body of research that sheds light on specific aspects that need neurorehabilitation, such as motor functions, in patients has favored the evolution of the neurorehabilitation devices market. According to a projection by Transparency Market Research, the global neurorehabilitation devices market will clock an impressive CAGR of 15.5% during 2016–2024.
Developing Paradigm of Neurologic Care to underpin New Avenues
In recent years, global populations suffering with neurological conditions have swelled, and so have the associated morbidities, notably adult-onset disability. With rapidly aging population, the numbers will only rise, which will call for novel neurorehabilitative devices for treatments. Advancement in the global neurorehabilitation market will also been influenced by changing needs of the patient population toward personalized therapies, along with aligning these devices to meet clinicians preferences. Developing paradigm of neurologic care will combine multiple aspects of neurorehabilitation, opening new frontiers in the market.
A variety of brain function assessment tools are being adopted by neurorehabilitation clinics. Developed nations, such as Canada and the U.S., are developing an appetite for objective brain function assessment systems. Neurorehabilitation devices that allow a rapid assessment neuro-physiological brain function in neurologic patients is a case in point.
NeuroCatch Inc., a neuro-health technology company, has unveiled a NeuroCatch Platform in this regard. Plus, they are considered easy-to-use and cost-effective. The ease of accessibility to clinicians and researchers has further stoked its popularity. A slew of approaches have been tested by researchers that will help neurologists and clinicians fully leverage the potential of emerging neurorehabilitation devices.
Request Brochure of Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=12791
Neurorehabilitation of Disabling Brain Disorders presents Considerable Opportunities
Products launches such as aforementioned boost the broader impetus for translating research innovations pertaining to neuroscience into real-world medical applications, thereby fueling the strides in the global neurorehabilitation devices. This will create scope of novel technologies for neurorehabilitation of disabling brain disorders such as traumatic brain injuries and strokes. This is especially prevalent in North America.
In Asia Pacific, the global neurorehabilitation devices market has been receiving a big stride from rising populations of disability caused by road accidents. Growing fatality from road traffic injuries in various parts of Asia is a case in point. The region has substantial chunk of worldwide populations suffering with traumatic brain injuries.
In various regions, the prevalence of central nervous system disorders, notably Parkinson’s disease, is a notable factor driving the demand for neurorehabilitation devices. The demand dynamic is most influenced in developed regions of the world.
Among the various key devices, neurorobotic systems held the leading share in the global neurorehabilitation devices market in 2015 and is projected to rise at prominent pace in the coming years.